Estonia Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Estonia Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: On account of higher-than-expected pharmaceutical sales in 2012, we have revised upwards our forecast for the market. Nevertheless, we remain of the opinion that the Estonian market will be of modest interest at best to drugmakers, due to its small overall market value. Still, an ageing population and sedentary lifestyles are contributing to the increasing cardiovascular and oncologic burden on the state healthcare system. This, in combination with base effects, means that long-term growth is expected to be significant, although the market will remain comparatively small for Central and Eastern Europe (CEE). Headline Expenditure Projections ?? Pharmaceuticals: EUR262mn … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103163. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/estonia-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions